Communiqué – RMAC

Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field


(March 9, 2017) Montreal Stem cell science belongs to Canada and it is powering regenerative medicine. Today, leaders from across this emerging sector have joined forces to advance the field, through the newly created Regenerative Medicine Alliance of Canada (RMAC). 

The global market for regenerative medicine is expected to exceed US$49 billion by 2021. Canada is well positioned to compete by moving its innovative treatments and therapies out of the lab and into the clinic. Countries around the world, including the U.S., Japan and the U.K., have already taken bold steps through investment and regulatory modernization to capture a significant piece of the market. Now is the time for Canada to act.

RMAC will serve as a mechanism to support strategic activity across the regenerative medicine sector. Members will work collaboratively to share information and identify strategies that will benefit the growth of the sector. Bolstering and aligning programs, training, policy and communication will all be central themes addressed by RMAC.

The initial concept for this alliance was conceived by members of the regenerative medicine community during a workshop on the state of regenerative medicine in Canada. The workshop was held by the Council of Canadian Academies in 2016. Their newly released report notes the importance of strategic coordination amongst the stem cell and regenerative medicine community.

“On behalf of RMAC members we welcome the Council’s report, which details Canada’s global strength in stem cell research,” said Dr. Michael Rudnicki, Interim Chair of RMAC. “It comes as no surprise that Canada continues to punch above its weight and that Canadian researchers are producing high impact work. Science is our competitive advantage.”

The Stem Cell Network (SCN) is proud to be one of the founding members of the alliance.  This initiative is an important step forward in building a cohesive regenerative medicine sector in Canada, one that will see innovative new therapies and treatments emerge for the benefit of patients. SCN also welcomes the Council’s report and notes its finding that Canada’s regenerative medicine field is both high quality and highly cited.



About the Regenerative Medicine Alliance of Canada: RMAC is a voluntary organization comprised of national, provincial and regional organizations that are committed to building a robust regenerative medicine sector in Canada. All members have mandates relevant to stem cell research and/or regenerative medicine. The founding members include: CCRM; the Centre for Drug Research and Development; CellCan; Medicine by Design; Ontario Institute for Regenerative Medicine; ThéCell; Canadian Stem Cell Foundation, and Stem Cell Network. Regenerative Medicine is commonly described as the process of replacing, engineering or regenerating human cells, tissues or organs to establish or restore normal function.

About the Stem Cell Network: Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’etre of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning. SCN’s mandate is to act as a catalyst for enabling the translation of stem cell research into clinical applications, commercial products and public policy. In just over 15 years SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace.

Cate Murray
RMAC Secretariat
613 979-6174